Foster Jon M 4

What Happened
Jon M. Foster, Executive Vice President and Chief Operating Officer of HCA Healthcare (HCA), received a grant of 11,945 stock appreciation rights (SARs) on January 29, 2026. The award is reported as a derivative grant (transaction code A) with an acquisition price of $0.00 — this is an equity compensation award, not a cash purchase or sale.

Key Details

• Transaction date: 2026-01-29; Form 4 filed: 2026-02-02.
• Award: 11,945 stock appreciation rights (SARs) reported at $0.00 acquisition price.
• Shares/derivatives owned after transaction: not specified in the provided filing excerpt.
• Footnote: The SARs vest in four equal annual installments beginning on January 29, 2027 (see footnote F1).
• Filing timeliness: Form filed on Feb 2 for a Jan 29 grant — check official filing for whether this met the SEC’s 2-business-day Form 4 deadline.

Context

• SARs are a derivative equity award that pay the appreciation in the stock price (typically cash or shares) rather than granting immediate stock ownership; they are not an outright purchase and do not indicate the insider spent personal funds.
• Vesting over four years means the economic benefit is spread over time and depends on future stock performance.
• Awards like this are routine components of executive compensation and do not on their own signal a buy or sell decision by the insider.